Ticker Details
Arcutis Biotherapeutics, Inc.
IPO Date:	January 31, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.61B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.58 | 3.32%
Avg Daily Range (30 D):	$0.53 | 2.39%
Avg Daily Range (90 D):	$0.53 | 2.22%

Institutional Daily Volume
Avg Daily Volume:	1.16M
Avg Daily Volume (30 D):	1.37M
Avg Daily Volume (90 D):	1.15M

Trade Size
Avg Trade Size (Sh.):	97
Avg Trade Size (Sh.) (30 D):	68
Avg Trade Size (Sh.) (90 D):	63

Institutional Trades
Total Institutional Trades:	2,443
Avg Institutional Trade:	$2.26M
Avg Institutional Trade (30 D):	$2.63M
Avg Institutional Trade (90 D):	$3.17M
Avg Institutional Trade Volume:	.16M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3M
Avg Closing Trade (30 D):	$5.73M
Avg Closing Trade (90 D):	$5.79M
Avg Closing Volume:	206.83K

News

May 8, 2026 @ 8:00 PM Arcutis Biotherapeutics Reports Inducement Grants ... Source: Na

May 6, 2026 @ 8:00 PM Arcutis Announces First Quarter 2026 Financial Res... Source: Na

Apr 15, 2026 @ 8:00 PM Arcutis to Report First Quarter 2026 Financial Res... Source: Na

Apr 8, 2026 @ 11:30 AM Arcutis Stock Up 65% as Director Sells 10,000 Shar... Source: Jonathan Ponciano

Feb 27, 2026 @ 9:00 PM Arcutis Management to Present at TD Cowen’s... Source: Na

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.03	$-.09	$.13
Diluted EPS	$-.03	$-.09	$.13
Revenue	$415.62M	$105.4M	$129.5M
Gross Profit	$377.98M	$95.61M	$117.82M
Net Income / Loss	$-2.38M	$-11.3M	$17.4M
Operating Income / Loss	$3.21M	$-9.09M	$18.39M
Cost of Revenue	$37.65M	$9.78M	$11.69M
Net Cash Flow	$-18.7M	$-8.03M	$-4.27M
PE Ratio